Ro vs Found: Care Model, Compounded Pathway, and Pricing

Published in the PlexusDx Education Hub, this article joins our evidence-led coverage of GLP-1 care models, compounding pathways, and inherited metabolic factors. Visit all Peptides & GLP-1 education.

This comparison is independent editorial content. PlexusDx has no affiliation with Ro or Found and earns nothing from referrals to either service.

Full head-to-head: PlexusDx vs Found →

Ro and Found are frequently shortlisted together, yet they are engineered differently. Ro is a vertically integrated telehealth-and-pharmacy stack with roots in men's health; Found is a weight-management subscription. This comparison examines those care models, the compounded 503A pathway both can use, how each presents pricing, and the metabolic biology that precedes either prescription. As of April 2026.

Comparing two vertically different builds

Ro and Found are assembled differently. Ro, from Roman Health, is a full-stack telehealth company with its own pharmacy operations and origins in men's health; Found is a focused weight-management subscription. Both operate virtually and can use compounded pathways, but Ro emphasizes integration across the care-and-fulfillment chain while Found emphasizes a single category.

Ro: an integrated pharmacy and care stack

Ro runs as subscription telehealth with substantial vertical integration. Its weight program typically includes virtual evaluation, provider-issued prescriptions, and either FDA-approved brand dispensing or compounded semaglutide and tirzepatide via licensed 503A pharmacies. The current structure is documented at Ro's official website.

Found: a weight-management subscription

Found keeps a narrower footprint centered on weight. Intake, clinician review, prescription, and follow-up follow the category pattern, with fulfillment through a retail or compounding pharmacy. Details are published on Found's official website.

The compounded 503A pathway explained

Both programs can rely on 503A compounding pharmacies, which prepare patient-specific medications under state and federal oversight. A compounded semaglutide or tirzepatide preparation is not an FDA-approved brand product; it is a compounded formulation dispensed under a valid prescription. Understanding which pathway an order uses matters more than the brand name on the invoice.

How each program presents its pricing

Pricing across GLP-1 telehealth varies widely as of April 2026, with typical monthly totals from roughly $200 to $700+ after program fees, medication, and compounded dispensing. Ro and Found each publish current figures on their own sites. Because numbers shift, verify directly on each brand's pricing page rather than trusting a snapshot.

The genetic variable no subscription reads

Here is the layer none of these telehealth workflows examine: the inherited biology that sets the stage before any GLP-1 molecule arrives. Inherited differences in FTO, GLP1R, and TCF7L2 (a transcription factor linked to glucose homeostasis) define the metabolic terrain that even a vertically integrated pharmacy does not read. These are pathway-level markers. They do not predict how you will respond to any particular drug, but they describe the metabolic terrain a prescriber is writing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that terrain, mapping appetite regulation, satiety, and energy-balance biology so a conversation with your own clinician starts from data rather than guesswork. It is not a pharmacogenomic test and never forecasts a medication's effect.

PlexusDx offers the same compounds — semaglutide and tirzepatide — through its Weight Management Protocols as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral, adding a genetic read that a pharmacy-integrated telehealth stack does not routinely provide.

Not affiliated: PlexusDx has no affiliation and no commercial relationship with Ro or the other programs discussed in this review.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Educational content. PlexusDx is not affiliated with Ro or Found and has no commercial relationship with either brand. PlexusDx provides semaglutide and tirzepatide through its own Weight Management Protocols; this review compares GLP-1 telehealth approaches. The Precision Peptide Genetic Test evaluates gene–pathway influence and does not predict medication response. See a qualified healthcare provider before any protocol.

Compare a genetics-first path: review the PlexusDx Weight Management Protocols, or run the Precision Peptide Genetic Test to see your GLP-1 pathway before selecting a program.

Frequently Asked Questions

Does Ro or Found handle its own pharmacy?

Ro is known for vertical integration, including pharmacy operations, while Found operates as a weight-focused subscription that routes prescriptions to retail or compounding pharmacies. Fulfillment structure differs, but both can dispense compounded semaglutide or tirzepatide through licensed 503A pathways. Confirm each program's current arrangement on its own website.

Are compounded GLP-1s from Ro and Found the same?

Compounded semaglutide and tirzepatide are prepared by licensed 503A pharmacies under a valid prescription, and neither is an FDA-approved brand product. The compound class is the same, but formulations, pharmacies, and oversight details can differ between programs. Ask which pathway and pharmacy any specific order uses before comparing.

Which program offers more transparent pricing?

Both publish current figures on their own sites, and transparency can change over time. Across GLP-1 telehealth as of April 2026, monthly totals commonly span roughly $200 to $700+ after fees, medication, and compounded dispensing. Read each brand's pricing page directly rather than trusting a possibly outdated snapshot.

What does a genetic test add before starting either?

It adds upstream context. The Precision Peptide Genetic Test maps pathway-level variants in FTO, and TCF7L2 that describe your baseline metabolism. It does not predict how Ro, Found, or any compound will perform for you, but it lets you begin from data instead of guesswork.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.